Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yeasen Biotechnology specializes in the development and large-scale production of enzymes, proteins, antibodies, nucleic acids, cell biology reagents, and related kits for life science research. The company has established itself as a leading supplier of high-quality molecular biology reagents—including GMP-grade enzymes for mRNA vaccine production—and has strategic partnerships with top sequencing service providers. Its platforms support applications from basic research to diagnostics to biopharma manufacturing. It does not develop or market finished pharmaceuticals or biologics but enables their development through its products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yeasen Biotechnology.